Eagle Pharmaceuticals, Inc. et al v. Hospira, Inc. > Summary
Court Case Number 1:21-cv-01619
Filing Date Nov 16, 2021
Termination Date Apr 19, 2022
Court Delaware District Court
Status Dismissed - Voluntarily
JudgesColm F. Connolly
Defendant
Plaintiff Attorneys
20Eagle Pharmaceuticals, Inc.
Attorney Name: Daniel G. Brown
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: Alex M. Grabowski
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Eagle Pharmaceuticals, Inc.
Attorney Name: Karen E. Keller
Shaw Keller LLP
Eagle Pharmaceuticals, Inc.
Attorney Name: Jennifer Koh
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: Kenneth G. Schuler
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: John W. Shaw
Shaw Keller LLP
Eagle Pharmaceuticals, Inc.
Attorney Name: Daniel M. Silver
McCarter & English
Eagle Pharmaceuticals, Inc.
Attorney Name: Marc N. Zubick
Latham & Watkins
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Karen E. Keller
Shaw Keller LLP
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: John W. Shaw
Shaw Keller LLP
Cephalon (Teva)
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Cephalon (Teva)
Attorney Name: Karen E. Keller
Shaw Keller LLP
Cephalon (Teva)
Attorney Name: John W. Shaw
Shaw Keller LLP
Cephalon (Teva)
Attorney Name: David I. Berl
Williams & Connolly
Cephalon (Teva)
Attorney Name: Adam D. Harber
Williams & Connolly
Eagle Pharmaceuticals, Inc.
Attorney Name: Michael A. Johnson
Latham & Watkins
Cephalon (Teva)
Attorney Name: Shaun P. Mahaffy
Williams & Connolly
Cephalon (Teva)
Attorney Name: Elise M. Baumgarten
Williams & Connolly
Defendant Attorneys
5Hospira
Attorney Name: Arthur G. Connolly III
Connolly Gallagher LLP
Hospira
Attorney Name: Ren-How H. Harn
Willkie Farr & Gallagher
Hospira
Attorney Name: Alan R. Silverstein
Connolly Gallagher LLP
Hospira
Attorney Name: Sara Horton
Willkie Farr & Gallagher
Hospira
Attorney Name: Melanie L. Lee
Willkie Farr & Gallagher
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
11103483 | Formulations of bendamustine | Aug 31, 2021 |
09579384 | Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration | Feb 28, 2017 |